A Clinical Study of Ultra-transplantation for the Treatment of Major Thalassemia Scheme
Recruiting
N/A
Interventional Study
Stem Cell Transplantation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 7 – 12
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 5 (estimated)
- Sponsor
- Hu Peng · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Yunnan is a high-incidence area of Eastern Mediterranean (thalassemia) in China, and the treatment cost of thalassemia patients is high, hematopoietic stem cell transplantation (HSCT) is the only means to cure thalassemia, but there are problems in donor screening and the risk of complications. Professor Ai Huisheng's team proposed a new concept of hypertransplantation, which does not require pret…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Patient inclusion criteria :
* Diagnosed with severe Mediterranean anemia, with no restrictions on alpha and beta types;
* Age between 7-12 years old, male or female not limited; Weight\<40kg
* The patient has or does not have HLA matched or semi matched donors, but unconditionally transplants or r…
Contacts